he YSK4 Activators are a diverse group of chemical compounds that enhance the functional activity of YSK4 through various indirect mechanisms. Compounds like cAMP and Forskolin, which manipulate the levels of secondary messengers, could influence the activity of YSK4 by modulating protein kinase A (PKA) and adenylate cyclase pathways, respectively. This modulation could lead to changes in phosphorylation states of proteins within these pathways, indirectly enhancing YSK4 activity. Similarly, Calcium Ionophore A23187 and W-7 Hydrochloride influence intracellular calcium levels and calmodulin activity, respectively. These changes could activate calcium-dependent kinases or phosphatases, affecting YSK4is part of calcium-signaling pathways.
Bisindolylmaleimide I, Genistein, LY294002, SB203580, U0126, PD98059, and Staurosporine represent a strategy of indirect activation through inhibition. By inhibiting specific kinases such as PKC, tyrosine kinases, PI3K, p38 MAPK, MEK, and a broad spectrum of other kinases, these compounds can lead to altered cellular signaling. This alteration might result in compensatory cellular responses or changes in signaling pathways, enhancing YSK4 activity. For instance, the inhibition of the MEK component of the MAPK/ERK pathway by U0126 or PD98059 could create a cellular environment where YSK4 activity is enhanced due to shifts in pathway dynamics. Similarly, Rapamycin's inhibition of mTOR could affect cellular processes like growth or autophagy, indirectly impacting YSK4 activity is involved in these processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP, a secondary messenger, could enhance YSK4 activity by activating PKA, which may phosphorylate substrates involved in pathways where YSK4 functions, potentially leading to its activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium, potentially activating calcium-dependent kinases or phosphatases that might modulate YSK4 through downstream signaling pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A PKC inhibitor, could indirectly enhance YSK4 activity by altering PKC-mediated signaling pathways, potentially affecting processes in which YSK4 is involved. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, Genistein could influence pathways involving tyrosine phosphorylation, indirectly affecting YSK4 activity if it interacts with these pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels and potentially enhancing YSK4 activity by influencing pathways related to cAMP signaling. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
A calmodulin inhibitor, could influence calcium signaling and potentially enhance YSK4 activity if YSK4 is involved in calcium-dependent pathways. | ||||||